Levodopa in the treatment of Parkinson’s disease: an old drug still going strong
Werner Poewe1, Angelo Antonini2, Jan CM Zijlmans3, Pierre R Burkhard4, François Vingerhoets51Department of Neurology, Medical University of Innsbruck, Austria; 2Parkinson Department, IRCCS San Camillo, Venice, and University of Padua, Italy; 3Department of Neurology, Amphia Hospital, Bred...
Saved in:
Main Authors: | Werner Poewe, Angelo Antonini, Jan CM Zijlmans, et al |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2010
|
Subjects: | |
Online Access: | https://doaj.org/article/e01cf434dee341bbbcb3f66eb12a8f0b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Profile of inhaled levodopa and its potential in the treatment of Parkinson’s disease: evidence to date
by: Patel AB, et al.
Published: (2018) -
The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -II
by: José-Francisco Rocha, et al.
Published: (2021) -
Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson's disease
by: Daniel D Truong
Published: (2009) -
Levodopa en la enfermedad de Parkinson: ¿Qué hemos aprendido?
by: Juri C,Carlos, et al.
Published: (2006) -
A comparison between Bromocriptine and Selegiline in treatment of Parkinsons disease
by: A Ahmadi Ahangar, et al.
Published: (2002)